Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens

OBJECTIVE: To evaluate immune responses to neoantigen and recall antigens in healthy subjects treated with teriflunomide. METHODS: This was a randomized, double-blind, placebo-controlled study. Subjects received oral teriflunomide (70 mg once daily for 5 days followed by 14 mg once daily for 25 days...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neurol Neuroimmunol Neuroinflamm
Päätekijät: Bar-Or, Amit, Wiendl, Heinz, Miller, Barry, Benamor, Myriam, Truffinet, Philippe, Church, Meg, Menguy-Vacheron, Francoise
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Lippincott Williams & Wilkins 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335822/
https://ncbi.nlm.nih.gov/pubmed/25738167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000070
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia